Clinical Trial Update: Open-label, Randomized Trial to Determine the Effect of Icodextrin Versus Dextrose (Dianeal 2.5%) in HOMA IR [Phase 4]

View source ↗

Summary

Phase 4 open-label randomized trial comparing icodextrin to dextrose (Dianeal 2.5%) in end-stage renal disease patients on continuous ambulatory peritoneal dial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• DEXTROSE (Dextrose monohydrate)
• Icodextrin (icodextrin)

Snippet

Sponsor: Vantive Health LLC | Conditions: End Stage Renal Disease, Continuous Ambulatory Peritoneal Dialysis | Phase 4 | Status: WITHDRAWN